BIOMX INC's ticker is PHGE and the CUSIP is 09090D103. A total of 15 filers reported holding BIOMX INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $11,648,000 | -23.3% | 2,133,402 | 0.0% | 1.19% | -39.5% |
| Q1 2021 | $15,190,000 | +11.6% | 2,133,402 | 0.0% | 1.97% | +12.1% |
| Q4 2020 | $13,611,000 | +0.6% | 2,133,402 | 0.0% | 1.76% | -35.5% |
| Q3 2020 | $13,526,000 | +14.9% | 2,133,402 | 0.0% | 2.72% | +17.7% |
| Q2 2020 | $11,776,000 | -21.1% | 2,133,402 | 0.0% | 2.31% | -71.5% |
| Q1 2020 | $14,934,000 | -27.7% | 2,133,402 | 0.0% | 8.13% | +9.1% |
| Q4 2019 | $20,662,000 | – | 2,133,402 | – | 7.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 2,133,402 | $11,648,000 | 1.19% |
| MMCAP International Inc. SPC | 684,451 | $3,737,000 | 0.18% |
| Orbimed Advisors | 2,313,489 | $12,632,000 | 0.13% |
| Taylor Wealth Management Partners | 31,804 | $174,000 | 0.06% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 14,207 | $78,000 | 0.04% |
| ROYCE & ASSOCIATES LP | 359,000 | $1,960,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 104,000 | $568,000 | 0.01% |
| J. Goldman & Co LP | 150,000 | $92,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 427,702 | $2,335,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,060 | $6,000 | 0.00% |